Primary_assembly X: 479,066-480,166 forward strand.
BDGP6.46:AE014298.5
This gene has 3 transcripts (splice variants), 16 orthologues and 2 paralogues.
| Name | Transcript ID | bp | Protein | Translation ID | Biotype | UniProt | RefSeq | Flags |
|---|---|---|---|---|---|---|---|---|
| CG32817-RC | FBtr0336919 | 837 | 121aa | FBpp0307856 | Gene/transcipt that contains an open reading frame (ORF).Protein coding | Q8IRY8 | - | A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1, |
| CG32817-RB | FBtr0300328 | 580 | 121aa | FBpp0289557 | Gene/transcipt that contains an open reading frame (ORF).Protein coding | Q8IRY8 | - | APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1, |
| CG32817-RA | FBtr0070077 | 532 | 121aa | FBpp0070076 | Gene/transcipt that contains an open reading frame (ORF).Protein coding | Q6NMY1 Q8IRY8 | - | APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1, |
![[RSS logo]](/i/rss_icon_16.png "Ensembl blog"){kind=icon}
![[twitter logo]](/i/twitter.png "Follow us on Twitter!")
